Prøve GULL - Gratis
Securing the pharma supply chain through traceability, transparency and technology
Express Pharma
|December 2024
Traceability has long been a challenge for the pharma supply chain. Yet, it is key to ensure good distribution practices and overcome the constant threat of counterfeiting drugs. Industry experts analyse the challenges, and strategise to safeguard the pharma supply chain
-

India needs to focus on reducing dependency on single sources by qualifying other geographies
There are several challenges in the traceability of the pharma supply chain. They mainly consist of controllable factors such as managing shipment time, lead time, temperature excursions, and maintaining quality checks, and uncontrollable factors such as the Red Sea Crisis increased lead time and planning.
Companies and the industry need to work towards enhancing end-to-end traceability by improving forecast accuracy and ensuring adherence to compliance. Efforts must be taken to reduce lag/lead time, avoid temperature excursion, and ensure that all related documentation is completed and filled correctly. India pharma Inc. needs to focus on reducing dependency on imports and dependency on single sources by qualifying other geographies. In order to ensure quality control, supplier qualifications must include quality testing (Nitrosamine + other tests from national/government labs of the country).
Available solutions
◆ Track and trace mechanisms to be installed and monitored with validation in place
◆ Datalogger real-time online tracking/monitoring
◆ Temperature challenge: Pharma companies focus mainly on cold chain and ensure that the products are transported across the length and breadth of the country using cold chain transportation. In India, we are seeing a boom of reefer vehicles which are being used across industries.
◆ Depute 'speciality couriers' rather than the regular freight forwarders. Speciality couriers have a very tight TAT and monitoring mechanism from end to end. A few companies to name, PDP, Ontime Globe, Alisped etc
◆ Companies have moved from traditional USB data loggers to smart IOT-based loggers which give real-time monitoring of temperature during the transit of the products and storage in warehouses.
Denne historien er fra December 2024-utgaven av Express Pharma.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Express Pharma

Express Pharma
Flexotherm Heating Tapes & Cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
October 2025

Express Pharma
DRIVING INDIA'S INNOVATION EDGE
Pharma leaders come together to highlight Bengaluru's R&D strength, tech ecosystem, and talent pool to power India Pharma Inc's shift from generics to innovation and global leadership
16 mins
October 2025

Express Pharma
Al compass: Transforming pharma commercialisation
As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging Al across nearly every aspect of commercialisation, from market forecasting and personalised marketing to dynamic pricing and beyond. In this article, Neha Aathavale takes the pulse of the industry to explore who is taking note and how companies are beginning to put Al into action in their commercial operations
7 mins
October 2025

Express Pharma
PRIME NEO: New age doors from Gandhi Automation
Gandhi Automations presents the multi-composites, high-performance door PRIME NEO for clean environments. Complete Washable, Greater Sealing and Pressure Resistant.
1 mins
October 2025

Express Pharma
Unani Medicine: At crossroads of tradition and modernity
Manufacturers, academic institutions and research councils are working together to elevate Unani medicine through clinical validation and policy alignment with international standards, finds Swati Rana
7 mins
October 2025

Express Pharma
Single-Use Technologies in Biologics Manufacturing: Benefits, Challenges, and Growing Demand
The biopharmaceutical industry is increasingly adopting single-use technology (SUT) to achieve flexibility, cost efficiency, and faster time-to-market. Compared with stainless steel systems, SUT reduces capital investment, eliminates cleaning and sterilization steps, lowers contamination risk, and shortens production timelines.
1 min
October 2025

Express Pharma
Sustainable packaging with Romaco and Liveo Research
Recycable blister packs
3 mins
October 2025

Express Pharma
With India soon to be three times the population of the EU, it makes perfect sense to have manufacturing here
As part of Sweden's Focus Asia programme, a high-level SME delegation recently visited India to strengthen bilateral ties and explore collaborations across sectors including pharma, biotech and others. Building on the momentum of the \"Time for Sweden\" event, the visit underscored Sweden's commitment to innovation, sustainability, and co-creation with India. Among the delegation was Emil Alexander Byström, CEO of SpinChem AB, who in an interaction with Kalyani Sharma shared his insights on how advanced Swedish technologies like biocatalysis and the company's patented Rotating Bed Reactor (RBR) can accelerate India's pharma and biotech innovation journey while supporting sustainable growth.
3 mins
October 2025

Express Pharma
Cell therapy's next chapter: Industry embraces in-vivo innovation
Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that cell therapy is entering a bold new phase in 2025 as the industry shifts from complex, lab-based ex vivo CAR-T to faster, more accessible in vivo CAR-T innovations. This approach promises to expand access, lower costs, and potentially tackle solid tumors and autoimmune diseases
4 mins
October 2025

Express Pharma
Research misconduct ...can delay meaningful and reliable discoveries
Dr Gráinne McNamara, Research Integrity/Publication Ethics Manager, S. Karger AG explores how research misconduct, peer review fraud slow down pharma research. Of particular concern to India is the fact that India-based researchers constitute 5 per cent of articles in life sciences retracted between 1976-2023. India-based researchers also have one of the highest rates of retraction relative to the overall publication output. Over an email exchange with Viveka Roychowdhury, she details how publishers are now deploying AI tools, some of which contributed to the problem in the first place, to detect and avert fraudulent research submissions
6 mins
October 2025
Listen
Translate
Change font size